8-K Announcements
6Material company update
Mar 2, 2026·SEC
Material company update
Feb 10, 2026·SEC
Material company update
Dec 29, 2025·SEC
Oscar Health, Inc.(OSCR)Earnings, Financials & Key Ratios
OSCR•NYSE•Insurance & Managed Care
$17.94
$4.71B mkt cap·Price updated May 6, 2026
AboutOscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.Show more
- Revenue$11.7B+27.5%
- Combined Ratio103.39%-42.4%
- Net Income-$443M-1842.5%
- Return on Equity-44.38%-1690.2%
- Medical Cost Ratio85.62%+7.2%
- Operating Margin-3.39%-1030.1%
- Net Margin-3.79%-1466.7%
- ROA-7.94%-1417.4%
- Equity / Assets15.5%-26.2%
- Book Value per Share3.74-2.2%
- Tangible BV/Share3.74-2.2%
- Debt/Equity0.44+48.8%
OSCR Key Insights
Oscar Health, Inc. (OSCR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗High loss ratio of 85.6%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
OSCR Price & Volume
Oscar Health, Inc. (OSCR) stock price & volume — 10-year historical chart
Loading chart...
OSCR Growth Metrics
Oscar Health, Inc. (OSCR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years81.77%
3 Years41.55%
TTM27.49%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-1842.49%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-4125%
Return on Capital
10 Years-24.44%
5 Years-24.84%
3 Years-11.56%
Last Year-25.31%
OSCR Recent Earnings
Oscar Health, Inc. (OSCR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (58%)
Q1 2026Latest
Feb 10, 2026EPS
$1.24
Est $0.92
-34.6%
Revenue
$2.7B
Est $3.1B
-12.1%
Q4 2025
Nov 6, 2025EPS
$0.53
Est $0.55
+3.6%
Revenue
$3.0B
Est $3.1B
-2.2%
Q3 2025
Aug 6, 2025EPS
$0.89
Est $0.90
+1.1%
Revenue
$2.9B
Est $3.1B
-6.8%
Q2 2025
May 7, 2025EPS
$0.92
Est $0.83
+10.8%
Revenue
$3.0B
Est $2.8B
+9.6%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $1.24vs $0.92-34.6% | $2.7Bvs $3.1B-12.1% |
| Q4 2025 | Nov 6, 2025 | $0.53vs $0.55+3.6% | $3.0Bvs $3.1B-2.2% |
| Q3 2025 | Aug 6, 2025 | $0.89vs $0.90+1.1% | $2.9Bvs $3.1B-6.8% |
| Q2 2025 | May 7, 2025 | $0.92vs $0.83+10.8% | $3.0Bvs $2.8B+9.6% |
Based on last 12 quarters of dataView full earnings history →
OSCR Peer Comparison
Oscar Health, Inc. (OSCR) competitors in Tech-Enabled Health Plans — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CLOV | 1.35B | 2.61 | -15.35 | 40.34% | -4.45% | -27.71% | ||
 ALHC | 3.74B | 18.30 | -4945.95 | 46.06% | 0.47% | 11.5% | 3.03% | 1.89 |
 ACGL | 33.54B | 94.14 | 8.10 | 14.27% | 22.07% | 19.02% | 18.27% | 0.11 |
 BHVN | 1.29B | 9.71 | -1.42 | -6.89% | 5.36 | |||
 MIRA | 40.3M | 1.02 | -2 | -376.4% | ||||
 UNH | 330.28B | 363.87 | 27.50 | 11.81% | 2.68% | 11.54% | 4.87% | 0.77 |
 CVS | 102.56B | 80.69 | 58.05 | 7.85% | 0.44% | 2.35% | 7.61% | 1.24 |
 CI | 72.68B | 275.66 | 12.43 | 11.26% | 2.26% | 15.08% | 11.54% | 0.75 |
Compare OSCR vs Peers
Oscar Health, Inc. (OSCR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OSCR Income Statement
Oscar Health, Inc. (OSCR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Revenue | 553.78M | 589.64M | 1.92B | 4.13B | 5.86B | 9.18B | 11.7B |
| Revenue Growth % | - | 6.48% | 225.78% | 114.77% | 42.11% | 56.54% | 27.5% |
| Medical Costs & Claims | 0 | 0 | 0 | 0 | 4.64B | 7.33B | 10.02B |
| Medical Cost Ratio % | 0% | 0% | 0% | 0% | 79.19% | 79.89% | 85.62% |
| Gross Profit | 553.78M▲ 0% | 589.64M▲ 6.5% | 1.92B▲ 225.8% | 4.13B▲ 114.8% | 5.86B▲ 42.1% | 9.18B▲ 56.5% | 1.68B▼ 81.7% |
| Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 14.38% |
| Gross Profit Growth % | - | 6.48% | 225.78% | 114.77% | 42.11% | 56.54% | -81.67% |
| Operating Expenses | 813.17M | 995.42M | 2.49B | 4.74B | 6.13B | 9.14B | 2.08B |
| OpEx / Revenue % | 146.84% | 168.82% | 129.7% | 114.79% | 104.56% | 99.64% | 17.77% |
| Depreciation & Amortization | 6.9M | 11.29M | 14.61M | 15.28M | 30.69M | 32.15M | 28.89M |
| Combined Ratio % | 146.84% | 168.82% | 129.7% | 114.79% | 183.75% | 179.53% | 103.39% |
| Operating Income | -259.39M▲ 0% | -405.78M▼ 56.4% | -570.58M▼ 40.6% | -610.08M▼ 6.9% | -267.3M▲ 56.2% | 33.43M▲ 112.5% | -396.36M▼ 1285.8% |
| Operating Margin % | -46.84% | -68.82% | -29.7% | -14.79% | -4.56% | 0.36% | -3.39% |
| Operating Income Growth % | - | -56.44% | -40.61% | -6.92% | 56.19% | 112.51% | -1285.77% |
| EBITDA | -252.49M | -394.5M | -555.98M | -594.79M | -236.61M | 65.57M | -367.46M |
| EBITDA Margin % | -45.59% | -66.9% | -28.94% | -14.42% | -4.04% | 0.71% | -3.14% |
| Interest Expense | 0 | 3.51M | 4.72M | 22.62M | 24.6M | 23.73M | 17.6M |
| Non-Operating Income | 0 | -3.51M | -4.72M | -22.62M | -24.6M | -23.73M | 23.34M |
| Pretax Income | -259.39M▲ 0% | -405.78M▼ 56.4% | -570.58M▼ 40.6% | -610.08M▼ 6.9% | -267.3M▲ 56.2% | 33.43M▲ 112.5% | -437.3M▼ 1408.3% |
| Pretax Margin % | -46.84% | -68.82% | -29.7% | -14.79% | -4.56% | 0.36% | -3.74% |
| Income Tax | 1.79M | 1.04M | 846K | -523K | 3.29M | 7.3M | 5.61M |
| Effective Tax Rate % | -0.69% | -0.26% | -0.15% | 0.09% | -1.23% | 21.85% | -1.28% |
| Net Income | -261.18M▲ 0% | -406.82M▼ 55.8% | -572.61M▼ 40.7% | -606.27M▼ 5.9% | -270.73M▲ 55.3% | 25.43M▲ 109.4% | -443.15M▼ 1842.5% |
| Net Margin % | -47.16% | -69% | -29.81% | -14.7% | -4.62% | 0.28% | -3.79% |
| Net Income Growth % | - | -55.76% | -40.75% | -5.88% | 55.35% | 109.39% | -1842.49% |
| EPS (Diluted) | -1.09▲ 0% | -1.70▼ 56.0% | -3.19▼ 87.6% | -2.85▲ 10.7% | -1.22▲ 57.2% | 0.10▲ 107.8% | -1.69▼ 1865.9% |
| EPS Growth % | - | -55.96% | -87.65% | 10.66% | 57.19% | 107.84% | -1865.94% |
| EPS (Basic) | -8.93 | -1.70 | -3.19 | -2.85 | -1.22 | 0.11 | -1.69 |
| Diluted Shares Outstanding | 239.31M | 239.31M | 178.97M | 212.47M | 221.66M | 265.85M | 262.39M |
OSCR Balance Sheet
Oscar Health, Inc. (OSCR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Total Assets | 1.35B | 2.27B | 3.32B | 4.53B | 3.6B | 4.84B | 6.33B |
| Asset Growth % | - | 68.69% | 46.19% | 36.28% | -20.44% | 34.4% | 30.68% |
| Total Investment Assets | 363.23M | 692.13M | 1.43B | 2.79B | 1.06B | 2.44B | 2.69B |
| Long-Term Investments | 333.75M | 366.39M | 844.48M | 1.4B | 365.31M | 1.82B | 1.47B |
| Short-Term Investments | 333.75M | 366.39M | 587.09M | 1.4B | 689.83M | 624.46M | 1.22B |
| Total Current Assets | 0 | 0 | 2.77B | 4.12B | 2.07B | 2.85B | 4.61B |
| Cash & Equivalents | 336.64M | 826.33M | 1.1B | 1.56B | 1.87B | 1.53B | 2.77B |
| Receivables | 55.19M | 96.48M | 611.06M | 49.86M | 494.39M | 315.89M | 442.64M |
| Other Current Assets | -725.59M | -1.29B | 463.86M | 1.12B | -982.95M | 377.64M | 180.15M |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 33.08M | 35.81M | 46.61M | 59.89M | 61.93M | 66.79M | 88.35M |
| Other Assets | -366.83M | -402.2M | -335.44M | -1.05B | 1.1B | 113.28M | 152.67M |
| Total Liabilities | 2.29B | 3.57B | 1.93B | 3.63B | 2.8B | 3.82B | 5.34B |
| Total Debt | 0 | 142.49M | 0 | 298M | 298.78M | 299.56M | 430.1M |
| Net Debt | -336.64M | -683.84M | -1.1B | -1.26B | -1.57B | -1.23B | -2.34B |
| Long-Term Debt | 0 | 142.49M | 0 | 298M | 298.78M | 299.56M | 430.1M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 1.62B | 3.26B | -175.28M | 3.17B | 4.86B |
| Accounts Payable | 589.07M | 655.23M | 718.81M | 1.37B | 1.03B | 1.4B | -99.75M |
| Deferred Revenue | 0 | 0 | 75.04M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -887.7M | -1.37B | 29.25M | 381.05M | -2.26B | 215.28M | 4.96B |
| Deferred Taxes | 0 | 0 | 1000K | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | -142.49M | 2.29B | 72.28M | 2.67B | 61.28M | 51.99M |
| Total Equity | -945.14M▲ 0% | -1.3B▼ 37.1% | 1.39B▲ 207.5% | 892.4M▼ 35.9% | 806.12M▼ 9.7% | 1.02B▲ 26.1% | 980.74M▼ 3.5% |
| Equity Growth % | - | -37.11% | 207.46% | -35.91% | -9.67% | 26.09% | -3.51% |
| Shareholders Equity | -945.14M | -1.3B | 1.39B | 890.38M | 803.97M | 1.01B | 977.65M |
| Minority Interest | 0 | 0 | 5.29M | 2.02M | 2.15M | 2.84M | 3.09M |
| Retained Earnings | -1.01B | -1.43B | -2B | -2.61B | -2.88B | -2.85B | -3.29B |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 3K |
| Accumulated OCI | -27K | 879K | -3.67M | -9.71M | 1.31M | -1.83M | 18.03M |
| Return on Equity (ROE) | - | - | -1185.16% | -53.07% | -31.88% | 2.79% | -44.38% |
| Return on Assets (ROA) | -19.39% | -22.48% | -20.47% | -15.45% | -6.66% | 0.6% | -7.94% |
| Equity / Assets | -70.17% | -57.03% | 41.92% | 19.71% | 22.38% | 21% | 15.5% |
| Debt / Equity | - | - | - | 0.33x | 0.37x | 0.29x | 0.44x |
| Book Value per Share | -3.95 | -5.42 | 7.78 | 4.20 | 3.64 | 3.82 | 3.74 |
| Tangible BV per Share | -3.95 | -5.42 | 7.78 | 4.20 | 3.64 | 3.82 | 3.74 |
OSCR Cash Flow Statement
Oscar Health, Inc. (OSCR) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -165.37M | 222.73M | -181.75M | 380.35M | -272.16M | 978.19M | 1.09B |
| Operating CF Growth % | - | 234.69% | -181.6% | 309.28% | -171.56% | 459.42% | 11.93% |
| Operating CF / Revenue % | -29.86% | 37.77% | -9.46% | 9.22% | -4.64% | 10.66% | 9.36% |
| Net Income | -261.18M | -406.82M | -571.43M | -609.55M | -270.59M | 26.12M | -442.9M |
| Depreciation & Amortization | 6.9M | 11.29M | 14.61M | 15.28M | 30.69M | 32.15M | 28.89M |
| Stock-Based Compensation | 33.56M | 35.87M | 86.3M | 112.33M | 159.68M | 109.82M | 87.65M |
| Deferred Taxes | -426K | -67K | -101K | -165K | 58K | -2.34M | 2.45M |
| Other Non-Cash Items | -6.43M | 6.77M | 41.19M | 7.46M | 86K | -26.42M | -40.24M |
| Working Capital Changes | 62.21M | 575.7M | 247.7M | 855M | -192.09M | 838.86M | 1.46B |
| Cash from Investing | 150.51M | -344.71M | -774.51M | -226.52M | 577.19M | -1.39B | -241.06M |
| Capital Expenditures | -26M | -14.02M | -25.89M | -29.01M | -25.58M | -27.9M | -36.37M |
| Acquisitions | 0 | 0 | 7.23M | 0 | 0 | 0 | 0 |
| Purchase of Investments | -877.67M | -1B | -1.81B | -1.19B | -836.98M | -2.13B | -1.01B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -7.08M | -1.24M | -555K | 1.12M | -2.28M | 3.93M | 4.28M |
| Cash from Financing | -2.12M | 611.71M | 1.24B | 301.11M | 6.45M | 68.39M | 399.21M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -2.99M | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 0 | 0 | 1.35B | 1.3M | 3.96M | 68.39M | 55.03M |
| Debt Issuance (Net) | 0 | 1000K | -1000K | 1000K | 0 | 0 | 1000K |
| Other Financing | 873K | 89.04M | 43.56M | -5.19M | 2.49M | 0 | -4.04M |
| Net Change in Cash | -16.98M▲ 0% | 489.73M▲ 2984.8% | 282.45M▼ 42.3% | 454.94M▲ 61.1% | 311.47M▼ 31.5% | -340.85M▼ 209.4% | 1.25B▲ 467.6% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 370.36M | 353.38M | 843.11M | 1.13B | 1.58B | 1.89B | 1.55B |
| Cash at End | 353.38M | 843.11M | 1.13B | 1.58B | 1.89B | 1.55B | 2.8B |
| Free Cash Flow | -191.37M▲ 0% | 208.71M▲ 209.1% | -207.63M▼ 199.5% | 351.34M▲ 269.2% | -297.74M▼ 184.7% | 950.3M▲ 419.2% | 1.06B▲ 11.4% |
| FCF Growth % | - | 209.06% | -199.48% | 269.21% | -184.74% | 419.17% | 11.38% |
| FCF Margin % | -34.56% | 35.4% | -10.81% | 8.52% | -5.08% | 10.35% | 9.05% |
| FCF per Share | -0.8 | 0.87 | -1.16 | 1.65 | -1.34 | 3.57 | 4.03 |
OSCR Key Ratios
Oscar Health, Inc. (OSCR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Combined Ratio | 146.84% | 168.82% | 129.7% | 114.79% | 183.75% | 179.53% | 103.39% |
| Medical Cost Ratio | 0% | 0% | 0% | 0% | 79.19% | 79.89% | 85.62% |
| Return on Equity (ROE) | - | - | -1185.16% | -53.07% | -31.88% | 2.79% | -44.38% |
| Return on Assets (ROA) | -19.39% | -22.48% | -20.47% | -15.45% | -6.66% | 0.6% | -7.94% |
| Equity / Assets | -70.17% | -57.03% | 41.92% | 19.71% | 22.38% | 21% | 15.5% |
| Book Value / Share | -3.95 | -5.42 | 7.78 | 4.2 | 3.64 | 3.82 | 3.74 |
| Debt / Equity | - | - | - | 0.33x | 0.37x | 0.29x | 0.44x |
| Revenue Growth | - | 6.48% | 225.78% | 114.77% | 42.11% | 56.54% | 27.5% |
OSCR SEC Filings & Documents
Oscar Health, Inc. (OSCR) SEC filings — annual & quarterly reports (10-K, 10-Q)
OSCR Frequently Asked Questions
Oscar Health, Inc. (OSCR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Oscar Health, Inc. (OSCR) grew revenue by 27.5% over the past year. This is strong growth.
Oscar Health, Inc. (OSCR) reported a net loss of $443.2M for fiscal year 2025.
Dividend & Returns
Oscar Health, Inc. (OSCR) has a return on equity (ROE) of -44.4%. Negative ROE indicates the company is unprofitable.
Industry Metrics
Oscar Health, Inc. (OSCR) has a combined ratio of 103.4%. A ratio above 100% means claims and expenses exceed premiums.
Explore More OSCR
Oscar Health, Inc. (OSCR) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates